Utah Administrative Code
Topic - Commerce
Title R156 - Professional Licensing
Rule R156-4a - Utah Professionals Health Program Rule
Section R156-4a-103b - Participation - UPHP Components and UPHP Participation Standards
Universal Citation: UT Admin Code R 156-4a-103b
Current through Bulletin 2024-18, September 15, 2024
(1) Under Section 58-4a-103, participation in the UPHP shall include the following components, as determined by the UPHP:
(a) an executed program contract or diversion
agreement;
(b) a comprehensive
clinical evaluation;
(c)
participation and attendance in treatment and continuing care with the
treatment providers approved by the UPHP;
(d) compliance monitoring;
(e) interstate monitoring;
(f) participant contact, including at least
quarterly reports by a worksite practice liaison;
(g) monthly or quarterly reports, including
at least quarterly reports by a therapist;
(h) medication logs;
(i) support group attendance;
(j) toxicology testing; and
(k) other components as determined by the
UPHP.
(2)
(a) Monitoring of a participant pursuant to
the terms and conditions of the program contract shall begin upon the
participant's execution of the program contract.
(b) If the program contract requires
residential or inpatient treatment instead of outpatient treatment, monitoring
under the program contract may commence after the participant completes the
residential or inpatient treatment.
(3) The following are established as the UPHP participation standards:
(a) A participant
shall abstain from the use of mind or mood altering substances, including
alcohol, medical cannabis, substances containing THC, inhalants, and illegal,
non-prescribed, and certain identified psychotropic over-the-counter
medications.
(b) A participant
shall abstain from the use of mind or mood altering, addictive, or potentially
addictive prescription medications, including amphetamine preparations,
opioids, sedatives, and benzodiazepines, except in an emergency such as
hospitalization due to emergency surgery, illness, or accident.
(c) A participant shall follow the UPHP
Medication Policy, which shall include the following participant requirements:
(i) provide UPHP with copies of
prescriptions, including controlled substances, received by the participant
during the term of the program contract;
(ii) receive medications for a participant's
own use only from treatment providers:
(A)
with whom the participant has a legitimate patient relationship; and
(B) who have signed an Acknowledgment of
Participation from UPHP regarding the participant's terms and conditions for
participating in UPHP;
(iii) provide UPHP information, or request
information for UPHP, regarding medications prescribed to the
participant;
(iv) if a participant
has a medical condition requiring potentially addictive substance use, or is
prescribed a controlled medication for any reason, comply with UPHP required
practice accommodations or limitations; and
(v) pursue effective alternatives or require
a second opinion prior to using any controlled or mind or mood altering
substances in a non-emergency situation.
(d) If a participant is at risk of impairment
for any reason, the participant shall comply with UPHP required practice
accommodations or limitations and not return to work until approved by the
UPHP.
(e) A participant may not
prescribe scheduled drugs for family members or for others who are not the
participant's legitimate patients within the scope of the participant's
practice, in accordance with applicable law, rule, or regulation.
(f) A participant shall prescribe only within
the scope of the participant's medical specialty, in accordance with applicable
law, rule, or regulation.
(g) A
participant shall provide current authorizations for the UPHP as determined
necessary by the UPHP, including authorization to:
(i) communicate with the participant's care
providers and treatment providers as needed to verify medical issues;
(ii) communicate with the participant's
worksite practice liaison;
(iii)
communicate with third parties such as emergency contacts and treatment
providers as determined necessary by the UPHP;
(iv) obtain information on medications
prescribed to the participant; and
(v) release information about the
participant's participation to the Division if required by the program contract
or Utah law.
(h) A
participant shall identify a primary care provider to manage the participant's
medical care and to comply with the participant's treatment plan, including
complying with the treatment provider recommendations and not self-prescribing
or independently discontinuing any medications.
(i) A participant shall follow the initial
treatment, medication management, and continuing care recommendations with
providers approved by the UPHP until treatment objectives are met as determined
by the treatment provider, and treatment is discontinued with the UPHP's
approval.
(j) A participant shall
attend a minimum number of mutual help group meetings or an alternative
approved by the UPHP, documented in a manner acceptable to the UPHP.
(k) A participant may not change or
discontinue therapy or treatment without approval of the participant's
therapist and UPHP.
(l) A
participant shall identify and cooperate with a worksite practice
liaison.
(m) A participant shall
comply with practice accommodations or limitations as required by:
(i) the participant's program
contract;
(ii) UPHP policies and
procedures; and
(iii) statutes and
rules pertaining to a compact in which Utah is a member.
(n) A participant shall submit to biological
specimen testing if requested by the UPHP.
(o) A participant shall participate in the
UPHP in good faith, and cooperate with UPHP staff.
(p) A participant shall comply with each UPHP
policy, including:
(i) the UPHP Return to Use
Behavior Policy; and
(ii) the UPHP
Medication Policy.
(q) A
participant shall notify the UPHP within 24 hours if the participant:
(i) has a medical or mental health
hospitalization;
(ii) has an
arrest, investigation, charge, or complaint, including a Division or other
regulatory agency complaint;
(iii)
receives a disciplinary notice from a regulatory agency, hospital, employer, or
other third party;
(iv) has any
adverse events affecting patient care including malpractice claims;
or
(v) returns to use of any
substances not approved by UPHP, including in cases of emergency use due to
illness or accident.
(r)
A participant shall notify the UPHP at least 24 hours:
(i) prior to the participant's anticipated
use of any controlled or mind or mood altering prescriptions or substances;
and
(ii) prior to the
participant's:
(A) travel outside UPHP's
jurisdiction;
(B) change of address
or phone number;
(C) change of
employment;
(D) engaging in
practice in another jurisdiction, state, or territory;
(E) applying for a license to practice in
another jurisdiction, state, or territory; or
(F) applying to participate in another
alternative to public discipline program.
(s) A participant shall maintain their Utah
license in active status while participating in UPHP.
Disclaimer: These regulations may not be the most recent version. Utah may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.